These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
883 related articles for article (PubMed ID: 34612781)
1. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma. Jiang W; Wu T; Shi X; Xu J Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma. Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005 [No Abstract] [Full Text] [Related]
3. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples. Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347 [TBL] [Abstract][Full Text] [Related]
5. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Xu H; Xiong C; Chen Y; Zhang C; Bai D Bioengineered; 2021 Dec; 12(1):2664-2675. PubMed ID: 34115569 [TBL] [Abstract][Full Text] [Related]
6. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
7. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes. Xiong C; Wang G; Bai D Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492 [TBL] [Abstract][Full Text] [Related]
8. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report. Lü Y; Zhang J; Li L; Li S; Yang Z Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034 [TBL] [Abstract][Full Text] [Related]
9. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
10. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
11. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
13. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
14. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma. Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086 [TBL] [Abstract][Full Text] [Related]
15. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related]
16. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation. Guo ZY; Jiang LP; Zhu ZT Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200 [TBL] [Abstract][Full Text] [Related]
17. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome. Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma. Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905 [TBL] [Abstract][Full Text] [Related]
19. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma. Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]